Drug Comparison Suits May Drive Shift In Pharma Ads
Several high-profile suits have been waged over the past year, including a fight that ended in June with the Second Circuit carving out significant protections for speech based on sound scientific research. And experts say more litigation is all but certain.
That’s in part because...
To view the full article, register now.